Research Article

Relationship between Surgery under General Anesthesia and the Development of Dementia: A Systematic Review and Meta-Analysis

Table 1

Study characteristics.

Study (1st author, year)
Region
Study designStudy populationSource of data extractionMethod of exposure assessmentOutcome definitionLag time; adjusted or matched covariatesGroup definitionStatistics
(95% CI)

Cohort study
Kim, 2018 [27]
South Korea
PCFrom the South Korean NHIS-NSC database.
free of dementia
Patient records on NHIS-NSC database files between 2002 and 2013GA operation codes in the NHIS-NSCdatabaseDementia (clinical diagnosis using ICD-10 codes and history of dementia medication)Did not included lag time; adjusted for gender, age group, health security system, health care visit frequency, and Charlson comorbidity indexHR
GA group449541.285 (1.214–1.361)
Age 60–69173871.216 (1.118–1.322)
56551.162 (1.059–1.276)
Unexposed group1744691.000
Age 60–69578671.000
Age> 69414611.000
Teipel, 2018 [31]
German
RCFrom the German statutory health insurance database.
Medical records from AOKHistory of joint replacement surgeryDementia (clinical diagnosis using ICD-10 codes)Included lag time; adjusted for cerebrovascular risk factors, age, sex, the presence of delirium, and regular prescription of sedative or analgesic drugs (SAD)No surgery154604Calculated HR
3.55 (3.13–4.03)
Quarter 010563
1-3 quarter0.95 (0.82–1.11)
4-6 quarter0.83 (0.70–0.97)
≥7 quarter0.91 (0.83–0.99)
Aiello Bowles, 2016 [30]
Washington, USA
PCAdult Changes in Thought (ACT) cohort which was randomly selected from members of Group Health (GH).
free of dementia
Self-reported data through interview at baseline and follow-upstudy visitsSelf-reported anesthesia data (reviewed by anesthesiologist)Dementia (DSM-IV)
AD (possible or probable AD by NINCDS-ADRDA)
Did not included lag time; adjusted for ACT study cohort, age, age at study entry, sex, education, hypertension, diabetes mellitus, smoking, stroke, coronary heart disease, exercise, self-rated health, body mass index, depression, Parkinson’s disease, Charlson comorbidity index, and difficulty with activities of daily living.High-risk surgery with GA248HR (dementia/AD)
0.86 (0.58–1.28)
0.95 (0.61–1.49)
Other surgery with GA33630.63 (0.46–0.85)
0.65 (0.46–0.93)
Other surgery with neuraxial anesthesia1230.49 (0.26–0.90)
0.62 (0.32–1.19)
No anesthesia group2541.00
1.00
Chen, 2014-1 [26]
Taiwan
RCLHID (a subset of the Taiwan NHIRD).
without history of cancer, dementia, parkinsonism, stroke, and brain surgery
Records from the LHID between 2004 and 2007Record of anesthesia from the LHIDDementia (clinical diagnosis using ICD-9-CM)Did not included lag time; matched for exact age and sex.
Cox regressions adjusted for hypertension, hyperlipidemia, depression, and Charlson index.
HR
Anesthesia group249011.75 (1.59–1.92)
General137151.46 (1.28–1.68)
IV or IM16861.60 (1.11–2.30)
Regional87771.80 (1.57–2.07)
Control group (4 or 5 patients selected for each person in anesthesia group)1109721.00
Zuo, 2010 [8]
Virginia, USA
RCFrom the CDR containing deidentified information of inpatients and outpatients in the University of Virginia Health System.Medical records from the CDRRecord of spine surgery under GAAD (clinical diagnosis using ICD-9-CM)Did not included lag time; noneSpine surgery group (from discectomy to fusion between 1992 and 2004)2881 ()Calculated OR using number of patients
0.67 (0.43–1.06)
No surgery group6157
()
1.00
Lee, 2005 [9] USARCVeterans Affairs (VA) patients undergoing CABG or PTCA between October 1996 and September 1997.
without AD
VA administrative databases of inpatient and outpatient encountersHistory of CABG (not mentioned about GA, but necessary)AD (clinical diagnosis using ICD-9)Did not included lag time; adjusted for age, number of surgeries, number of diagnoses, and length of stay for index hospitalization.CABG group (including patients who had both CABG and PTCA)5216HR
1.71 (1.02–2.87)
PTCA group39541.00
Case-control studies
Strand, 2019 [62]
Sweden
CCCase: Swedish Dementia Quality Registry, diagnoses of AD, late-onset AD, early-onset AD, and mixed Alzheimer’s and vascular dementia in the county of Östergötland from May 2007 to April 2012
Control: selected from the Statistics Sweden
Medical recordsMedical record of prior GA with gasDementia (diagnoses of AD, late-onset AD, early-onset AD, and mixed Alzheimer’s and vascular dementia from the dementia registry)Did not included lag time; adjusted for age category, sex, hypotension under anesthesia, total time anesthesia, and number of exposures of anesthesia.Cases457OR
2.47 (1.17–5.22)
Controls4201.00
Huang, 2018 [63]
China
CCCase: residents in Shenyang, China, who were diagnosed with dementia between January 2007 and December 2012
Control: matched for every case via the medical reports archival system
Medical records from Chinese database of inhabitants of ShenyangMedical record of prior GADementia (DSM-IV)
AD (DSM-IV)
Did not included lag time; matched for sex and age (within 1 year).CasesOR
Dementia5770.81 (0.71–1.09)
AD4850.89 (0.61–1.01)
Controls
Dementia5771.00
AD4851.00
Chen, 2014-2 [25]
Taiwan
NCCLHID (a subset of the NHIRD).

Case: newly diagnosed from 2005 to 2009
Control: 4-fold frequency matched
Medical records from the LHIDRecord of endotracheal tube intubation GADementia (clinical diagnosis using ICD-9-CM)Did not included lag time; matched randomly by age (every 5 years of age), sex, and index year. Adjusted for age, sex, depression, diabetes mellitus, hypertension, stroke, and atherosclerosis.Dementia group5345OR
1.34 (1.25–1.44)
Control group213801.00
Sprung, 2013 [59]
Minnesota, USA
NCCFrom residents of Olmsted County using Rochester Epidemiology Project (REP).
Case: diagnosed between 1985 and 1994
Control: matched for each case
Medical records from the REPMedical record of exposure to GA between age 45 and the index dateDementia (DSM-IV)
AD (DSM-IV, NINCDS-ADRDA)
Did not included lag time; matched randomly by sex and age (within 1 year).CasesOR (dementia/AD)
Dementia8770.89 (0.73–1.10)
AD7320.88 (0.71–1.11)
Controls
Dementia8771.00
AD7321.00
Bufill, 2009 [61]
Spain
NCCFrom subjects in COGMANLLEU study (belonging to the basic health care area of Manlleu).
Interview with participants and their relatives or caregiversSelf- or surrogate-reportedAD (DSM-IV, NINCDS-ADRDA)Did not included lag time; matched for age and gender.
Adjusted for age.
Cases51OR
3.22 (1.03–10.09)
Controls491.00
Yip, 2006 [28]
England and Wales, UK
NCCFrom Cognitive Function and Ageing Study (CFAS).

Case/control defined based on two times of interview
Interview with participantSelf-reported exposure to GADementia (AGECAT algorithm)Did not included lag time; adjusted for age, sex, education, and social class.Cases:
Dementia at wave 2/3
133/142OR (wave 2/3/both)
0.7 (0.4–1.1)
0.6 (0.3–1.0)
0.6 (0.4–0.9)
Controls:
Wave 2/3
2453/13471.0
1.0
1.0
Harmanci, 2003 [14]
Turkey
CCRandomly selected from population registries (records of the Muhtars’ list).

Case: probable AD patients
Control: cognitively normal individuals identified by neurologic examination.
Interview with proxy informantsSurrogate-reported history of GAAD (probable AD by NINCDS-ADRDA)Did not included lag time; adjusted for level of education, use of electricity for residential heating, and occupational group.Cases57OR
1.2 (0.58–2.48)
Controls1271.0
Gasparini, 2002 [29]
Italy
CCRecruited at the Department of Neurological Sciences of “La Sapienza” University of Rome, who were treated between January 1990 and June 1997.
Each case was matched for 4 controls (2 PD and 2 other disease)
Hospital recordsHospital record of exposure to GA in the 1-year and 5-year periods prior to onset of neurological disease.AD (probable AD by NINCDS-ADRDA)Did not included lag time; matched for sex, age (within 3 years), and geographical area of residence.Cases115Calculated OR
1.03 (0.60–1.75)
Controls (PD)2301.00
Controls (others)230
Tyas, 2001 [60]
Canada
CCRandomly sampled from a list provided by the provincial health insurance plan.
Interview and questionnaireSelf-reported exposure to GAAD (probable or possible AD by NINCDS-ADRDA)Did not included lag time; adjusted for age, sex, education.Cases36RR
0.61 (0.22–1.63)
Controls6581.00
Bohnen, 1994 [10]
Minnesota, USA
CCCase: selected from patients with AD developed between 1975 and 1984 in Olmsted County by reviewing medical records
Control: matched for each AD case from Olmsted County Mayo Clinic patients
Medical recordsAnesthesia records for GAAD (clinical diagnosis using their own preselected specific criteria)Did not included lag time; matched for age, sex.Cases252OR
1.28 (0.82–2.00)
Controls2521.00
CHSA, 1994 [57]
Canada
CCRecruited from both the community and institutions in Canada.
Risk factor questionnaires completed by proxy respondentsSurrogate-reported exposure to GAAD (probable AD by NINCDS-ADRDA)Did not included lag time; frequency matching by study center, residence in community or institution, and age group
Adjusted for age, sex, residence, and education
Cases258OR
1.07 (0.60–1.90)
Controls5351.00
Li, 1992 [15] ChinaCCCases: Clinically diagnosed AD inpatients or outpatients from 1988 to 1989.
Controls: Selected from the neighborhoods of the matched cases.
Direct interview using a structured and standardized questionnaire with surrogate informant.Surrogate-reported history of GAAD
(probable AD by NINCDS-ADRDA, ICD-10)
Did not included lag time;
Matched by age (within 3 years) and sex.
Cases70OR
0.62 (0.20–1.86)
Controls1401.00
Kokmen, 1991 [11]
Minnesota, USA
CCCases: Rochester, Minnesota, residents with onset of AD between 1960 and 1974 using the existing medical records resource.
Controls: matched for each case by searching the registration system at Mayo Clinic.
Entire community medical records.Medical record of prior GAAD (clinical diagnosis by reviewing clinical and postmortem data)Did not included lag time; matched by age (within years), sex, and duration of community medical record.Cases415OR
0.86 (0.60–1.21)
Controls4151.00
Graves, 1990 [56]
Washington, USA
CCCases: patients living in Washington state who were diagnosed with AD between January 1980 and June 1985.
Controls: friend, relative or surrogate of the cases.
Interview with surrogate respondentsSurrogate-reported history of surgery with GAAD (DSM-III, NINCDS-ADRDA)Did not included lag time; matched by sex and age (within 10 years).
Adjusted for age in the reference year.
Cases130OR
1.21 (0.54–2.73)
Controls1301.00
Broe, 1990 [58]
Australia
CCCases: from consecutive new referrals to dementia clinics in Sydney by general practitioners (GPs).
Controls: a person matched for each case from same GP’s files.
Interview with the informants of the cases and controlsSurrogate-reported exposure to GAAD (probable or possible AD by NINCDS-ADRDA)Did not included lag time; matched for sex and age within 2 years.
Matched pairs odds ratio was calculated.
Cases170OR
0.95 (0.50–1.81)
Controls1701.00
Amaducci, 1986 [12] ItalyCCCases: Patients admitted to the neurology departments of the seven centers between 1982 and 1983.
Controls: 1 hospital (from same hospital) and 1 population control (neighbor, a friend, or an acquaintance) was identified for each case
Interview with a surrogate respondent.Surrogate-reported exposure to GAAD
(clinical diagnosis using their own criteria)
Did not included lag time;
Matched for age (within 3 years), sex, and region of residence.
Matched-pair analysis were used.
Cases116Calculated OR
1.00 (0.38–2.66)
Controls (hospital)1161.00
Controls (population)97
Heyman, 1984 [13]
USA
CCCases: participants in a comprehensive clinical, genetic, and epidemiological study of AD at Duke University Medical Center.
Control: 2 matched subjects selected by the telephone sampling technique of random-digit dialing.
Structured interview with a close family member.Surrogate-reported history of surgery with GAAD (clinical diagnosis using their own diagnostic procedure)Did not included lag time; matched for sex, race, 5-year age interval (50-54, 55-59, etc.), and residential area.Cases40Calculated OR
0.63 (0.20–1.96)
Controls801.00

Abbreviations. : number of subjects; CI: confidence interval; HR: hazard ratio; OR: odds ratio; RR: relative risk; AD: Alzheimer’s disease; GA: general anesthesia; PC: prospective cohort study; RC: retrospective cohort study; NCC: nested case-control study; CC: case-control study; ICD-10: International Classification of Diseases, 10th Revision; ICD-9-CM: International Classification of Diseases, 9th Revision, Clinical Modification; DSM-III: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; NINCDS-ADRDA: National Institutes of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders; AGECAT: Automated Geriatric Examination for Computer Assisted Taxonomy; NHIS-NSC: National Health Insurance Service-National Sample Cohort; LHID: Longitudinal Health Insurance Database; NHIRD: National Health Insurance Research Database; AOK: Allgemeine Ortskrankenkasse; CDR: Clinical Data Repository; CABG: coronary artery bypass graft; PTCA: percutaneous transluminal coronary angioplasty; PD: Parkinson’s disease; CHSA: The Canadian Study of Health and Aging.